Form 4: Medpace Holdings President Exercises Stock Options
SEC Form 4 Filing
Medpace Holdings President, Jesse J. Geiger, exercised stock options for 15,000 shares at a price of $32.05 per share.
Summary
- Jesse J. Geiger, President of Medpace Holdings, Inc., exercised stock options on December 6, 2024.
- He acquired 15,000 shares of common stock at a price of $32.05 per share.
- This transaction increased his direct holdings to 36,503 shares.
- The stock options were granted previously and vested on February 28, 2022.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard executive compensation practice. It doesn't indicate any positive or negative sentiment about the company's performance.
Industry Context
This is a routine transaction for a company executive and is not unusual. It is common for executives to exercise stock options as part of their compensation.
Comparison to Industry Standards
- Stock option exercises are a standard part of executive compensation packages in the pharmaceutical and biotech industries.
- The vesting period of the options is typical for such grants.
- The exercise price is set at the time of the grant and is not unusual.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it increases the number of shares outstanding.
Key Dates
| Date | Description |
|---|---|
| 02/28/2022 | The date the stock options vested. |
| 12/06/2024 | The date the stock options were exercised. |
| 12/10/2024 | The date the Form 4 was signed. |
Keywords
stock options, insider trading, Medpace Holdings, equity, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.